Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 17(8): e0268881, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36001537

RESUMO

PURPOSE: To evaluate the value of convolutional neural network (CNN) in the diagnosis of human brain tumor or Alzheimer's disease by MR spectroscopic imaging (MRSI) and to compare its Matthews correlation coefficient (MCC) score against that of other machine learning methods and previous evaluation of the same data. We address two challenges: 1) limited number of cases in MRSI datasets and 2) interpretability of results in the form of relevant spectral regions. METHODS: A shallow CNN with only one hidden layer and an ad-hoc loss function was constructed involving two branches for processing spectral and image features of a brain voxel respectively. Each branch consists of a single convolutional hidden layer. The output of the two convolutional layers is merged and fed to a classification layer that outputs class predictions for the given brain voxel. RESULTS: Our CNN method separated glioma grades 3 and 4 and identified Alzheimer's disease patients using MRSI and complementary MRI data with high MCC score (Area Under the Curve were 0.87 and 0.91 respectively). The results demonstrated superior effectiveness over other popular methods as Partial Least Squares or Support Vector Machines. Also, our method automatically identified the spectral regions most important in the diagnosis process and we show that these are in good agreement with existing biomarkers from the literature. CONCLUSION: Shallow CNNs models integrating image and spectral features improved quantitative and exploration and diagnosis of brain diseases for research and clinical purposes. Software is available at https://bitbucket.org/TeslaH2O/cnn_mrsi.


Assuntos
Doença de Alzheimer , Neoplasias Encefálicas , Doença de Alzheimer/diagnóstico por imagem , Neoplasias Encefálicas/diagnóstico por imagem , Humanos , Aprendizado de Máquina , Imageamento por Ressonância Magnética/métodos , Redes Neurais de Computação
2.
Anal Chim Acta ; 1185: 338872, 2021 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-34711307

RESUMO

White blood cells protect the body against disease but may also cause chronic inflammation, auto-immune diseases or leukemia. There are many different white blood cell types whose identity and function can be studied by measuring their protein expression. Therefore, high-throughput analytical instruments were developed to measure multiple proteins on millions of single cells. The information-rich biochemistry information may only be fully extracted using multivariate statistics. Here we show an overview of the most essential steps for multivariate data analysis of single cell data. We used white blood cells (immunology) as a case study, but a similar approach may be used in environment or biotech research. The first step is analyzing the study design and subsequently formulating a research question. The three main designs are immunophenotyping (finding different cell types), cell activation and rare cell discovery. When preparing the data it is essential to consider the design and focus on the cell type of interest by removing all unwanted events. After pre-processing, the ten-thousands to millions of single cells per sample need to be converted into a cellular distribution. For immunophenotyping a clustering method such as Self-Organizing Maps is useful and for cell activation a model that describes the covariance such as Principal Component Analysis is useful. In rare cell discovery it is useful to first model all common cells and remove them to find the rare cells. Finally discriminant analysis based on the cellular distribution may highlight which cell (sub)types are different between groups.


Assuntos
Análise de Dados , Proteômica , Análise por Conglomerados , Análise Multivariada , Proteínas
3.
Comput Biol Med ; 41(2): 87-97, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21236418

RESUMO

In order to evaluate the relevance of magnetic resonance (MR) features selected by automatic feature selection techniques to build classifiers for differential diagnosis and tissue segmentation two data sets containing MR spectroscopy data from patients with brain tumours were investigated. The automatically selected features were evaluated using literature and clinical experience. It was observed that a significant part of the automatically selected features correspond to what is known from the literature and clinical experience. We conclude that automatic feature selection is a useful tool to obtain relevant and possibly interesting features, but evaluation of the obtained features remains necessary.


Assuntos
Neoplasias Encefálicas/diagnóstico , Biologia Computacional/métodos , Processamento de Imagem Assistida por Computador/métodos , Imageamento por Ressonância Magnética/métodos , Análise de Variância , Química Encefálica , Neoplasias Encefálicas/metabolismo , Neoplasias Encefálicas/patologia , Diagnóstico Diferencial , Análise Discriminante , Humanos , Meningioma/diagnóstico , Meningioma/metabolismo , Meningioma/patologia , Metástase Neoplásica/patologia , Estatísticas não Paramétricas
4.
Mol Oncol ; 4(3): 209-29, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20537966

RESUMO

Triple-negative breast cancers (TNBC), characterized by absence of estrogen receptor (ER), progesterone receptor (PR) and lack of overexpression of human epidermal growth factor receptor 2 (HER2), are typically associated with poor prognosis, due to aggressive tumor phenotype(s), only partial response to chemotherapy and present lack of clinically established targeted therapies. Advances in the design of individualized strategies for treatment of TNBC patients require further elucidation, by combined 'omics' approaches, of the molecular mechanisms underlying TNBC phenotypic heterogeneity, and the still poorly understood association of TNBC with BRCA1 mutations. An overview is here presented on TNBC profiling in terms of expression signatures, within the functional genomic breast tumor classification, and ongoing efforts toward identification of new therapy targets and bioimaging markers. Due to the complexity of aberrant molecular patterns involved in expression, pathological progression and biological/clinical heterogeneity, the search for novel TNBC biomarkers and therapy targets requires collection of multi-dimensional data sets, use of robust multivariate data analysis techniques and development of innovative systems biology approaches.


Assuntos
Neoplasias da Mama/fisiopatologia , Receptor ErbB-2/metabolismo , Receptores de Estrogênio/metabolismo , Receptores de Progesterona/metabolismo , Antineoplásicos/uso terapêutico , Proteína BRCA1/genética , Proteína BRCA1/metabolismo , Proteína BRCA2/genética , Proteína BRCA2/metabolismo , Biomarcadores Tumorais/metabolismo , Neoplasias da Mama/epidemiologia , Neoplasias da Mama/patologia , Neoplasias da Mama/terapia , Feminino , Humanos , Medicina de Precisão , Receptor ErbB-2/genética , Receptores de Estrogênio/genética , Receptores de Progesterona/genética , Biologia de Sistemas/métodos
5.
Anal Chem ; 75(20): 5352-61, 2003 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-14710812

RESUMO

A new classification approach was developed to improve the noninvasive diagnosis of brain tumors. Within this approach, information is extracted from magnetic resonance imaging and spectroscopy data, from which the relative location and distribution of selected tumor classes in feature space can be calculated. This relative location and distribution is used to select the best information extraction procedure, to identify overlapping tumor classes, and to calculate probabilities of class membership. These probabilities are very important, since they provide information about the reliability of classification and might provide information about the heterogeneity of the tissue. Classification boundaries were calculated by setting thresholds for each investigated tumor class, which enabled the classification of new objects. Results on histopathologically determined tumors are excellent, demonstrated by spatial maps showing a high probability for the correctly identified tumor class and, moreover, low probabilities for other tumor classes.


Assuntos
Ácido Aspártico/análogos & derivados , Neoplasias Encefálicas/classificação , Processamento de Imagem Assistida por Computador/métodos , Imageamento por Ressonância Magnética/métodos , Ácido Aspártico/análise , Encéfalo/patologia , Química Encefálica , Neoplasias Encefálicas/diagnóstico , Líquido Cefalorraquidiano/química , Colina/análise , Creatina/análise , Análise Discriminante , Ácidos Graxos/análise , Glioma/classificação , Glioma/diagnóstico , Ácido Glutâmico/análise , Humanos , Inositol/análise , Ácido Láctico/análise , Espectroscopia de Ressonância Magnética , Seleção de Pacientes , Análise de Componente Principal , Probabilidade , Sensibilidade e Especificidade , Distribuições Estatísticas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA